BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30427093)

  • 1. Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy.
    Saadipoor A; Razzaghdoust A; Simforoosh N; Mahdavi A; Bakhshandeh M; Moghadam M; Abdollahi H; Mofid B
    Phytother Res; 2019 Feb; 33(2):370-378. PubMed ID: 30427093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer.
    Hille A; Schmidberger H; Hermann RM; Christiansen H; Saile B; Pradier O; Hess CF
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1488-93. PubMed ID: 16137837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.
    Jahraus CD; Bettenhausen D; Malik U; Sellitti M; St Clair WH
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1483-7. PubMed ID: 16099600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily sodium butyrate enema for the prevention of radiation proctitis in prostate cancer patients undergoing radical radiation therapy: results of a multicenter randomized placebo-controlled dose-finding phase 2 study.
    Maggio A; Magli A; Rancati T; Fiorino C; Valvo F; Fellin G; Ricardi U; Munoz F; Cosentino D; Cazzaniga LF; Valdagni R; Vavassori V
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):518-24. PubMed ID: 24803033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial.
    Kneebone A; Mameghan H; Bolin T; Berry M; Turner S; Kearsley J; Graham P; Fisher R; Delaney G
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):628-35. PubMed ID: 11597802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis.
    O'Brien PC; Franklin CI; Dear KB; Hamilton CC; Poulsen M; Joseph DJ; Spry N; Denham JW
    Radiother Oncol; 1997 Nov; 45(2):117-23. PubMed ID: 9424000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy.
    Sandoughdaran S; Razzaghdoust A; Tabibi A; Basiri A; Simforoosh N; Mofid B
    Urol J; 2021 Apr; 18(3):295-300. PubMed ID: 32350847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of acute radiation-induced Proctitis by Aloe vera: a prospective randomized, double-blind, placebo controlled clinical trial in Pelvic Cancer patients.
    Sahebnasagh A; Ghasemi A; Akbari J; Alipour A; Lashkardoost H; Ala S; Hosseinimehr SJ; Salehifar E
    BMC Complement Med Ther; 2020 May; 20(1):146. PubMed ID: 32404169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 2 randomized controlled trial of oral resistant starch supplements in the prevention of acute radiation proctitis in patients treated for cervical cancer.
    Sasidharan BK; Ramadass B; Viswanathan PN; Samuel P; Gowri M; Pugazhendhi S; Ramakrishna BS
    J Cancer Res Ther; 2019; 15(6):1383-1391. PubMed ID: 31898677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients.
    Khan AM; Birk JW; Anderson JC; Georgsson M; Park TL; Smith CJ; Comer GM
    Am J Gastroenterol; 2000 Aug; 95(8):1961-6. PubMed ID: 10950043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we decrease the acute proctitis in prostate cancer patients using hyaluronic acid during radiation therapy: a prospective historically controlled clinical study.
    Stefanelli A; Pascale G; Rainieri E; Ursino S; Colella M; Zini G; Berretta M; Fiorica F
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):639-45. PubMed ID: 22774405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study.
    Sanguineti G; Franzone P; Marcenaro M; Foppiano F; Vitale V
    Strahlenther Onkol; 2003 Jul; 179(7):464-70. PubMed ID: 12835883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unwanted side-effects in using mesalazine (5-aminosalicylic acid) during radiotherapy].
    Freund U; Schölmerich J; Siems H; Kluge F; Schäfer HE; Wannenmacher M
    Strahlenther Onkol; 1987 Oct; 163(10):678-80. PubMed ID: 3313776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a prostaglandin--given rectally for prevention of radiation-induced acute proctitis--on late rectal toxicity. Results of a phase III randomized, placebo-controlled, double-blind study.
    Kertesz T; Herrmann MK; Zapf A; Christiansen H; Hermann RM; Pradier O; Schmidberger H; Hess CF; Hille A
    Strahlenther Onkol; 2009 Sep; 185(9):596-602. PubMed ID: 19756426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium butyrate enemas in the treatment of acute radiation-induced proctitis in patients with prostate cancer and the impact on late proctitis. A prospective evaluation.
    Hille A; Herrmann MK; Kertesz T; Christiansen H; Hermann RM; Pradier O; Schmidberger H; Hess CF
    Strahlenther Onkol; 2008 Dec; 184(12):686-92. PubMed ID: 19107351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Synbiotics to Reduce Symptoms and Rectal Inflammatory Response in Acute Radiation Proctitis: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial.
    Nascimento M; Caporossi C; Eduardo Aguilar-Nascimento J; Michelon Castro-Barcellos H; Teixeira Motta R; Reis Lima S
    Nutr Cancer; 2020; 72(4):602-609. PubMed ID: 31364875
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategic evaluation of interventions to prevent consequential late proctitis after prostate radiation therapy: new clinical trial designs should be considered.
    Showalter TN; Wages NA; Ohri N
    Cancer Biol Ther; 2014 Apr; 15(4):361-4. PubMed ID: 24521697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucralfate or placebo following argon plasma coagulation for chronic radiation proctitis: a randomized double blind trial.
    Chruscielewska-Kiliszek MR; Regula J; Polkowski M; Rupinski M; Kraszewska E; Pachlewski J; Czaczkowska-Kurek E; Butruk E
    Colorectal Dis; 2013 Jan; 15(1):e48-55. PubMed ID: 23006660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial.
    Nascimento M; Aguilar-Nascimento JE; Caporossi C; Castro-Barcellos HM; Motta RT
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):289-95. PubMed ID: 25304789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of hepcidin plasma and urine levels is associated with acute proctitis and changes in hemoglobin levels in primary radiotherapy for prostate cancer.
    Christiansen H; Saile B; Hermann RM; Rave-Fränk M; Hille A; Schmidberger H; Hess CF; Ramadori G
    J Cancer Res Clin Oncol; 2007 May; 133(5):297-304. PubMed ID: 17393200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.